checkAd

AusCann !!! (Seite 18)

eröffnet am 24.06.18 15:11:52 von
neuester Beitrag 20.03.23 21:31:39 von

ISIN: AU000000AC89 · WKN: A2DLBP · Symbol: ACNNF
0,0049
 
USD
+23,74 %
+0,0009 USD
Letzter Kurs 29.03.23 · Nasdaq OTC

Beitrag zu dieser Diskussion schreiben

  • 1
  • 18
  • 20

Begriffe und/oder Benutzer

 

Top-Postings

 Ja Nein
    Avatar
    23.11.18 10:40:05
    Beitrag Nr. 23 ()
    Avatar
    30.10.18 13:11:10
    Beitrag Nr. 22 ()
    Avatar
    27.09.18 15:10:21
    Beitrag Nr. 21 ()
    Antwort auf Beitrag Nr.: 58.578.026 von Popeye82 am 31.08.18 06:11:02"AusCann Announces Leadership Transition"
    http://emarketing.dashdigital.com.au/t/ViewEmail/j/0F1D9D186…
    Avatar
    31.08.18 06:11:02
    Beitrag Nr. 20 ()
    1 Antwort
    Avatar
    20.08.18 18:59:18
    Beitrag Nr. 19 ()
    und canopy growth hat die Beteiligung erhöht
    Avatar
    20.08.18 18:32:24
    Beitrag Nr. 18 ()
    Avatar
    02.08.18 18:23:30
    Beitrag Nr. 17 ()
    Antwort auf Beitrag Nr.: 58.222.329 von Hyper-Hyper am 16.07.18 11:24:15Das Resultat sieht man eindeutig am Aktienkurs.
    Avatar
    16.07.18 11:24:15
    Beitrag Nr. 16 ()
    Oh Auscann was tust du deinen Aktionären an
    1 Antwort
    Avatar
    05.07.18 15:00:23
    Beitrag Nr. 15 ()
    SX-listed medical cannabis firm AusCann Group Holdings Ltd has successfully completed the placement of 30.4 million shares that netted the company A$33.4 million ($25 million) in fresh capital. In a disclosure to the Australia Securities Exchange, AusCann said the placement was made to investors from North America and Australia, including AusCann’s major shareholder, Canopy Growth Corporation, which, following completion of the placement, will increase its ownership to 11.2 per cent. The placement represents 30.4 million new fully paid ordinary shares in AusCann under an issue price of A$1.10, an 11.7 per cent discount on the weighted average price of its shares over the 15-day prior period of trade. Based in Australia, AusCann seeks to produce clinically validated cannabinoid medicines. It initially targets medications for neuropathic and chronic pain in Australia and Chile, while exploring global export opportunities.

    Read more at: https://www.dealstreetasia.com/stories/auscann-cannabis-plac…
    Avatar
    05.07.18 09:53:00
    Beitrag Nr. 14 ()
    AusCann Completes A$33.4 million Placement
    • 1
    • 18
    • 20
     DurchsuchenBeitrag schreiben


    AusCann !!!